SAN DIEGO, Nov. 29, 2016/PRNewswire/ - Los Angeles occupant Wendy Knecht recorded a claim yesterday[11/28/16] in Los Angeles Superior Court asserting that her plastic specialist, Max R. Lehfeldt, M.D., of Teleos Plastic Surgery, schemed with therapeutic gadget maker Allergan, Inc., to advance and utilize SERI surgical platform and Natrelle bosom tissue expanders in her in an off-mark, test way without her insight. She has sued Dr. Lehfeldt and his practice for medicinal carelessness, rupture of guardian obligation, absence of educated assent and extortion. She sued Allergan for carelessness, extortion, and inability to caution and is looking for correctional harms.
As indicated by the grievance documented by San Diego Attorney Robert Vaage, the SERI surgical platform never got freedom by the FDA for use in bosom reproduction or with the Natrelle bosom expanders. The protestation goes ahead to charge that Dr. Lehfeldt had a broad budgetary/look into association with Allergan, with money related and examine premiums in the SERI and Natrelle items. He has gone about as a speaker and "employee" for Allergan, and counseled on the utilization and promoting of Allergan items. The protestation claims that Dr. Lehfeldt was paid by Allergan to advance and utilize its items, and at the time he treated Ms. Knecht, Dr. Lehfeldt was a primary examiner for a continuous FDA-authorized clinical study in regards to the utilization of the SERI framework with the Natrelle bosom expanders in bosom recreation surgery. Ms. Knecht was unconscious of Dr. Lehfeldt's broad association with Allergan or his monetary and research interests in the SERI and Natrelle items.
"At the point when a specialist has broad budgetary ties with a gadget producer and is included in a continuous clinical trial, he has an obligation to disclose that data to his patient," clarified Vaage. "Ms. Knecht did not have any of the securities she would have had as a knowing member in a clinical trial. There's simply no logical verification/clinical proof that this SERI surgical platform, which is gotten from silk, is protected to use in bosom reproduction surgery. Dr. Lehfeldt realized that; Allergan realized that. Shockingly, Ms. Knecht did not."
Ms. Knecht charges that the SERI surgical platform and Natrelle bosom tissue expanders fizzled and created her wounds, abandoning her distorted and requiring extra reconstructive surgery to evacuate the Allergan gadgets and repair the harm done. Ms. Knecht had twofold mastectomies due to her high hereditary danger of creating bosom tumor.
For more data concerning this claim, please contact The Law Offices of Robert Vaage at 619-338-0505 or email rfvaage@vaagelaw.com. Robert F. Vaage is a trial lawyer in San Diego, California. He has spoken to patients in misrepresentation cases including doctors and therapeutic gadget makers.
As indicated by the grievance documented by San Diego Attorney Robert Vaage, the SERI surgical platform never got freedom by the FDA for use in bosom reproduction or with the Natrelle bosom expanders. The protestation goes ahead to charge that Dr. Lehfeldt had a broad budgetary/look into association with Allergan, with money related and examine premiums in the SERI and Natrelle items. He has gone about as a speaker and "employee" for Allergan, and counseled on the utilization and promoting of Allergan items. The protestation claims that Dr. Lehfeldt was paid by Allergan to advance and utilize its items, and at the time he treated Ms. Knecht, Dr. Lehfeldt was a primary examiner for a continuous FDA-authorized clinical study in regards to the utilization of the SERI framework with the Natrelle bosom expanders in bosom recreation surgery. Ms. Knecht was unconscious of Dr. Lehfeldt's broad association with Allergan or his monetary and research interests in the SERI and Natrelle items.
"At the point when a specialist has broad budgetary ties with a gadget producer and is included in a continuous clinical trial, he has an obligation to disclose that data to his patient," clarified Vaage. "Ms. Knecht did not have any of the securities she would have had as a knowing member in a clinical trial. There's simply no logical verification/clinical proof that this SERI surgical platform, which is gotten from silk, is protected to use in bosom reproduction surgery. Dr. Lehfeldt realized that; Allergan realized that. Shockingly, Ms. Knecht did not."
Ms. Knecht charges that the SERI surgical platform and Natrelle bosom tissue expanders fizzled and created her wounds, abandoning her distorted and requiring extra reconstructive surgery to evacuate the Allergan gadgets and repair the harm done. Ms. Knecht had twofold mastectomies due to her high hereditary danger of creating bosom tumor.
For more data concerning this claim, please contact The Law Offices of Robert Vaage at 619-338-0505 or email rfvaage@vaagelaw.com. Robert F. Vaage is a trial lawyer in San Diego, California. He has spoken to patients in misrepresentation cases including doctors and therapeutic gadget makers.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.